Bio-Engineered Mosquitoes to be Released In U.S.
Bio-engineered mosquitoes will be released in many parts of the United States next year in an attempt to reduce wild populations of mosquitoes that can transmit diseases such as Zika, yellow fever and Dengue fever.
The lab-grown male Asian Tiger mosquitoes are infected with bacteria that prevents reproduction, but does not pose a risk to other insects or animals, according to Kentucky-based MosquitoMate, US News & World Report said.
The release of the bio-engineered mosquitoes in 20 states and Washington, D.C. was approved by the Environmental Protection Agency on Nov. 3 and the program will start next summer, according to a report in the journal Nature.
Release of the mosquitoes was not approved in much of the southeastern U.S. because MosquitoMate has not yet performed field trials there. The company recently completed a successful trial in Florida and plans to submit an application to the EPA for nationwide use of its mosquitoes.
Similar projects are underway in Brazil and China, according to US News & World Report said.
Posted: November 2017
Read this next
THURSDAY, Oct. 8, 2020 -- The Zika epidemic, which began as a mosquito-borne viral infection and led to severe birth defects, affected far more people than previously thought, new...
TUESDAY, Oct. 6, 2020 -- The sting of fire ants can be painful and even deadly -- and the threat rises during fall across the southeastern United States. At this time of year,...
MONDAY, Sept. 28, 2020 -- Climate change could give West Nile virus a boost in some areas of the United States, but reduce its spread in other regions, a new study suggests. The...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.